Quantcast

Posts related to ‘MRK’

All 30 DJIA Dividend Trends into 2012, Stock by Stock (DIA, AA, AXP, T, BAC, BA, CAT, CVX, CSCO, KO, DD, XOM, GE, HD, HPQ, IBM, INTC, JNJ, JPM, KFT, MCD, MMM, MRK, MSFT, PFE, PG, TRV, UTX, VZ, WMT, DIS)

The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain for companies to continue returning capital to shareholders while also ...
Read Full Story »

24/7 Closing Bell (AMD, FSLR, POT, PAAS, S, OXY, CVX, CSTR, MRK, BIDU, WY, IPG, SWC, ALGN, STMP, CPSI, CODE, DRIV)

Markets opened slightly lower this morning and spent the morning trying to decide on a direction. The Reuters/University of Michigan Consumer Sentiment Index rose more than expected, but even ...
Read Full Story »

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring ...
Read Full Story »

R&D Spenders Get No Respect

A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is the conclusion of a new study by Booz & Co., ...
Read Full Story »

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will ...
Read Full Story »

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription ...
Read Full Story »

Media Digest (9/29/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke says the Fed may have to act if inflation falls ...
Read Full Story »

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month bond.  The participation rate was strong enough that this still ...
Read Full Story »

The 2011 Layoff Kings (BSX, CSCO, DAL, GCI, GS, HBC, LMT, MRK, RIMM, SHLD, CS, UBS, MS, ESRX, MHS)

Financial markets have been reeling as investors grow more concerned about the economy: An S&P downgrade of the full faith and credit of the United States, dismal GDP data, and ...
Read Full Story »

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Once patent protection expires on a prescription drug, the drug's maker can take a serious beating in revenue and profitability. One way to make up for the loss is to ...
Read Full Story »

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning.  The results of both drug behemoths are largely in line with ...
Read Full Story »

National Employee Morale Day At Merck (MRK)

Merck (NYSE: MRK) released an unusual earnings announcement. It is profitable, has a bright future, and will fire about 13,000 people. These employees can leave with the knowledge that they ...
Read Full Story »

Top Earnings Previews For The Week Ahead (BIDU, NFLX, MMM, AMZN, BIIB, FSLR, F, JNPR, COP, GMCR, V, WFM, ALU, CHK, S, SBUX, TYC, AMGN, ITT, MRK)

Earnings season is in full throttle and many major companies are due to report in the week ahead.  Some of the key reports we are featuring for detailed earnings previews ...
Read Full Story »

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition.  ...
Read Full Story »

Short Sellers Savage The Macro-Caps Across The Board

No industry was able to avoid short selling activity, particularly among its largest companies. Tech, automotive, conglomerates, consumer goods, and financial shares were all under pressure, and big firms took ...
Read Full Story »